4
Changes in Ownership
Jade Biosciences, Inc. Filed Acc 0001415889-24-009243
Dake Benjamin T sold 3,432 shares at $28.01 ($96,119)
- Dake Benjamin T acquired 3,432 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-25 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,432 | $10.61 | $36,414 | 4,723 | D |
| 2024-03-25 | Sale : show line 2 in the form 10b5-1 | −3,432 | $28.01 | $96,119 | 1,291 | D |
| Open-market sales · 3,432 sh · avg $28.01 · $96,119 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-03-25 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −3,432 | 40,068 | D |
Loading xslF345X05/form4-03272024_060301.xml…